The wait is over! Pharma giants Sun, Dr. Reddy’s, and Glenmark have shattered the price barrier by launching generic semaglutide in India.

Affordability: Weekly costs plummet to as low as ₹325. Impact: Millions gain access to life-changing diabetes and obesity treatment. Science: Same active molecule, fraction of the price.

Consult your doctor and join the future of accessible healthcare today!